{"id":2792,"date":"2023-10-18T16:13:55","date_gmt":"2023-10-18T16:13:55","guid":{"rendered":"https:\/\/infundpros.com\/markets\/baxter-and-5-more-medical-device-stocks-primed-to-bounce-back\/"},"modified":"2023-10-18T16:13:56","modified_gmt":"2023-10-18T16:13:56","slug":"baxter-and-5-more-medical-device-stocks-primed-to-bounce-back","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=2792","title":{"rendered":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-BAR-0000771714\">\n<div data-layout=\"wrap\n              \" data-layout-mobile=\"\" class=\"\n        media-object\n        type-InsetMediaIllustration\n          wrap\n  article__inset\n        article__inset--type-InsetMediaIllustration\n          article__inset--wrap\n    article__inset--lead\n  \"><\/p>\n<p>        <!-- eventually when we know what this card will be we can change it and leave this one --><\/p>\n<figure class=\"\n        media-object-image\n        enlarge-image\n        img-wrap\n        article__inset__image\n      \" itemscope=\"\" itemtype=\"http:\/\/schema.org\/ImageObject\"><\/p>\n<\/figure><\/div>\n<p>The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the stocks.<\/p>\n<p>The<br \/>\n        iShares U.S. Medical Devices ETF<br \/>\n       (ticker:<br \/>\n        IHI<br \/>\n      ) is down about 13% on the year through Monday\u2019s close, while the<br \/>\n        S&amp;P 500<br \/>\n       has climbed roughly 14%. Shares of some major players in the sector have fallen even farther:<br \/>\n        Abbott Laboratories<br \/>\n       (ABT) is down 16% this year, while<br \/>\n        Baxter International<br \/>\n       (BAX) has dived 37%.<\/p>\n<div class=\"paywall\">\n<p>Since the summer, investors have grown increasingly worried that the new weight-loss drugs from<br \/>\n        Eli Lilly<br \/>\n       (LLY) and<br \/>\n        Novo Nordisk<br \/>\n       (NVO) will bring on vast changes in Americans\u2019 health, which could undermine demand for many of the products sold by medical device companies.<\/p>\n<p>\u201cThe basic thought process here is that excess weight is the root of many ailments ranging from cardiac artery disease to sleep apnea,\u201d Mizuho analyst Anthony Petrone wrote in a Tuesday note. \u201cHence, if you solve for excess weight, demand for surgery could wane over time.\u201d<\/p>\n<p>Such fears have led to \u201c$370 billion total market cap destruction across U.S. MedTech,\u201d Petrone wrote.<\/p>\n<p>Despite the selloff, however, it remains unclear exactly how the new obesity drugs will affect medical device companies. In an interview with <em>Barron\u2019s<\/em> on Tuesday,<br \/>\n        Johnson &amp; Johnson<br \/>\n       (JNJ) CFO Joe Wolk noted that people with obesity may not be eligible for some procedures\u2014like knee and hip replacements\u2014but that they could become eligible with weight loss.<\/p>\n<p>\u201cIt remains to be seen, it\u2019s early days,\u201d Wolk said of the obesity drugs\u2019 impact on his company\u2019s medtech business.<\/p>\n<p>For investors, that uncertainty means an opportunity for stock-picking.<\/p>\n<div data-layout=\"edgetoedge\n              \" data-layout-mobile=\"\" class=\"\n        media-object\n        type-InsetDynamic\n          edgetoedge\n    scope-web|mobileapps\n  article__inset\n        article__inset--type-InsetDynamic\n          article__inset--edgetoedge\n  \"><\/p>\n<p>        <!-- eventually when we know what this card will be we can change it and leave this one --><\/p>\n<div class=\"dynamic-inset-container article__inset__dynamic \">\n<div id=\"screen1018-kazis-c5f9a1a7-ccef-48b5-9bef-01cfd03e2fa0-container\" class=\"wsj-data-table\" data-publication=\"barrons\">\n<table id=\"screen1018-kazis-c5f9a1a7-ccef-48b5-9bef-01cfd03e2fa0-table\">\n<thead>\n<th>Company \/ Ticker<\/th>\n<th>Recent Price<\/th>\n<th>YTD Change<\/th>\n<th>Market value (mil)<\/th>\n<th>Average price target<\/th>\n<th>Implied potential upside<\/th>\n<\/thead>\n<tbody>\n<tr>\n<td><b>Insulet \/ PODD<\/b><\/td>\n<td>$135.91<\/td>\n<td>-53.8%<\/td>\n<td>$9,489.4<\/td>\n<td>$271.37<\/td>\n<td>99.7%<\/td>\n<\/tr>\n<tr>\n<td><b>DexCom \/ DXCM<\/b><\/td>\n<td>78.95<\/td>\n<td>-30.3<\/td>\n<td>30,622.5<\/td>\n<td>137.84<\/td>\n<td>74.6<\/td>\n<\/tr>\n<tr>\n<td><b>Penumbra \/ PEN<\/b><\/td>\n<td>200.09<\/td>\n<td>-10.1<\/td>\n<td>7,690.8<\/td>\n<td>314.38<\/td>\n<td>57.1<\/td>\n<\/tr>\n<tr>\n<td><b>Baxter International \/ BAX<\/b><\/td>\n<td>31.98<\/td>\n<td>-37.3<\/td>\n<td>16,194.8<\/td>\n<td>49.50<\/td>\n<td>54.8<\/td>\n<\/tr>\n<tr>\n<td><b>ResMed \/ RMD<\/b><\/td>\n<td>141.24<\/td>\n<td>-32.1<\/td>\n<td>20,774.3<\/td>\n<td>202.04<\/td>\n<td>43.0<\/td>\n<\/tr>\n<tr>\n<td><b>Zimmer Biomet Holdings \/ ZBH<\/b><\/td>\n<td>105.05<\/td>\n<td>-17.6<\/td>\n<td>21,951.7<\/td>\n<td>146.19<\/td>\n<td>39.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"wsj-interactive-source\">Source: FactSet<\/p>\n<\/div><\/div>\n<\/p><\/div>\n<p>To identify medical device stocks with room to grow, we screened the iShares U.S. Medical Devices ETF for companies with market values over $5 billion and with average analyst target prices implying the largest potential upside. The idea was to find the medical device stocks that analysts have the most faith in.<\/p>\n<p>The stocks that passed the screen all are down significantly in the current selloff. They include<br \/>\n        Insulet<br \/>\n       (PODD), which sells a wearable insulin management system, and<br \/>\n        DexCom<br \/>\n       (DXCM), which sells a wearable glucose monitor. Both products face a theoretical challenge from the new obesity medicines, which are also very effective at controlling Type 2 diabetes.<\/p>\n<p>Insulet\u2019s average analyst price target is roughly double its recent price, while<br \/>\n        DexCom<br \/>\n      \u2018s average price target is roughly 75% above its recent price.<\/p>\n<p>Other stocks to pass the screen include Baxter,<br \/>\n        Penumbra<br \/>\n       (PEN),<br \/>\n        ResMed<br \/>\n       (RMD), and<br \/>\n        Zimmer Biomet Holdings<br \/>\n       (ZBH).<\/p>\n<p>Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com<\/p>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/articles\/medical-device-stocks-weight-loss-drugs-36d8dc6a?mod=markets\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2793,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":{"0":"post-2792","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-markets"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros<\/title>\n<meta name=\"description\" content=\"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=2792\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros\" \/>\n<meta property=\"og:description\" content=\"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=2792\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-18T16:13:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-18T16:13:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1697645635_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=2792#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=2792\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"Baxter and 5 More Medical Device Stocks Primed to Bounce Back\",\"datePublished\":\"2023-10-18T16:13:55+00:00\",\"dateModified\":\"2023-10-18T16:13:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=2792\"},\"wordCount\":484,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=2792#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=2792\",\"url\":\"https:\/\/infundpros.com\/?p=2792\",\"name\":\"Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2023-10-18T16:13:55+00:00\",\"dateModified\":\"2023-10-18T16:13:56+00:00\",\"description\":\"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=2792#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=2792\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=2792#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baxter and 5 More Medical Device Stocks Primed to Bounce Back\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros","description":"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=2792","og_locale":"en_US","og_type":"article","og_title":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros","og_description":"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the","og_url":"https:\/\/infundpros.com\/?p=2792","og_site_name":"inFundPros","article_published_time":"2023-10-18T16:13:55+00:00","article_modified_time":"2023-10-18T16:13:56+00:00","og_image":[{"width":1280,"height":640,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1697645635_social.jpeg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=2792#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=2792"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back","datePublished":"2023-10-18T16:13:55+00:00","dateModified":"2023-10-18T16:13:56+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=2792"},"wordCount":484,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=2792#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=2792","url":"https:\/\/infundpros.com\/?p=2792","name":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2023-10-18T16:13:55+00:00","dateModified":"2023-10-18T16:13:56+00:00","description":"The share prices of medical device companies have been circling the drain this year, as worries over the impact of the new obesity medicines weigh on the","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=2792#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=2792"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=2792#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"Baxter and 5 More Medical Device Stocks Primed to Bounce Back"}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/2792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2792"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/2792\/revisions"}],"predecessor-version":[{"id":2794,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/2792\/revisions\/2794"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/2793"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}